A key aim of this research group is to understand the skins responses to environmental signals (including drugs, chemicals, foreign antigens and ultraviolet radiation).
Major themes of research include:
There is a strong emphasis on inter-disciplinary working and the integration of clinical investigation and basic research as highlighted by a close working relationship between the clinical dermatology and the academic departments, based within the Institute of Cellular Medicine and the Institute of Genetic Medicine and The Newcastle Cancer Centre .
We encourage imaginative and multidisciplinary approaches and have particular expertise in:
We foster a vibrant, interactive and collaborative environment as evidenced by multiple joint grants, joint supervision of research students and scientific publications. The group comprises Principal Investigators (PIs) from Dermatology, Pharmacology, Haematology, Toxicology and Medical Physics within ICM and IGM. In addition, Principal Investigators have collaborations across other research institutes (eg IAH, ICAMB, IGM, NESCI, NICR) and research groups (eg Cell Signalling, Nanotechnology).
Our research environment is enhanced by key external collaborations promoting exchange of ideas and expertise. These include links within and outwith UK/Europe:
We place a strong emphasis on postgraduate and post-doctoral training and have an active weekly programme both within ICM and dermatology (clinical and basic science journal clubs, research in progress meetings) and play a key role in running the MRes in Medical and Molecular Biosciences.
Many of our clinical trainees pursue higher research degrees funded through external nationally funded fellowships and our PhD students have secured both prestigious fellowships (European Commission) and post-doctoral positions (e.g. Khavari lab, Stanford; Buck Institute, San Francisco; NIH, Bethesda; Sydney University, Australia). In 2006/2007 we were one of only three units in England and Wales to be awarded academic clinical fellowships in dermatology through a national competition and a Walport/NIHR Lectureship was recently established. Currently, we have two Wellcome intermediate clinical fellows in post, a unique achievement amongst UK dermatology units.
Dermatology is one of six priority areas supported through a Wellcome Clinical Research Training Fellowship Scheme in Translational Medicine and Therapeutics at Newcastle University which provides up to four fellowships per year for the next five years. This scheme is designed principally to provide training for clinicians in translational research to PhD level in Newcastle.
We encourage relevant commercialisation of our research through both consultancy and the establishment of spin out companies such as Genesis Genomics UK (2002, now Mitomics) and Powerhouse biologics Ltd (2011) both of which have attracted significant government and private funding.
Our research is supported by key links and industrial collaborations (BBSRC and EPSRC CASE studentships with Unilever, AstraZeneca, GSK and Procter and Gamble) and links with regional funding agencies. We have four CASE awards currently running, one with Stiefel, a GSK company and the other two with Unilever and Procter and Gamble. In addition we have three knowledge transfer partnerships (KTPs) involving international cosmetic and pharmaceutical companies.
We interact with local patient groups and promote public engagement in Science through fund raising and educational events (eg NESRF, mini Medical School), Science Media Centre Science Road Show, VITAE, The Royal Institution)
|
Professor Mark Birch-Machin
|
|
|
Professor Ann Daly
|
|
|
Professor Anne Dickinson
|
|
|
Emeritus Professor Brian Diffey
|
|
|
Professor Peter Farr
|
|
|
Dr Muz Haniffa
|
|
|
Dr James Lloyd
|
|
|
Dr Penny Lovat
|
|
|
Dr Neil Rajan
|
|
|
Dr Julia Reichelt
|
|
|
Professor Nick Reynolds
|
|
|
Dr Sophie Weatherhead
|
|
|
Professor Faith Williams
|
|